Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenshe Ray Liu

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|June 29, 2026
Ubiquitin Chloromethylketone Probe Enables Activity-based, Selective Protein Profiling of E2 Ubiquitin Conjugating EnzymesSaibal Chanda, Alan Pham, Yugendar R Alugubelli, et al.
Chemmedchem|August 23, 2021
Drug Repurposing for the SARS-CoV-2 Papain-Like ProteaseChia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, et al.
Biochemistry|April 15, 2026
Phage Display Driven Identification and Computational Mapping of Macrocyclic Peptides Targeting RhoA G17VSebin Abraham, Chaoyang Zhu, Lai Hoang Son Le, et al.
Chemmedchem|July 9, 2021
MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin LXinyu R Ma, Yugendar R Alugubelli, Yuying Ma, et al.
Journal of the American Chemical Society|March 28, 2020
Expressed Protein Ligation without InteinYuchen Qiao, Ge Yu, Kaci C Kratch, et al.
ACS Chemical Biology|September 29, 2022
Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2J Trae Hampton, Tyler J Lalonde, Jeffery M Tharp, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Bepridil is potent against SARS-CoV-2 In VitroErol C Vatansever, Kai Yang, Kaci C Kratch, et al.
Current Research in Chemical Biology|July 11, 2022
Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main proteaseKai S Yang, Syuan-Ting Alex Kuo, Lauren R Blankenship, et al.
ACS Central Science|April 29, 2024
Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein InhibitorsPeng-Hsun Chase Chen, Xuejiao Shirley Guo, Hanyuan Eric Zhang, et al.
ACS Chemical Biology|January 11, 2023
A Novel Y-Shaped, S-O-N-O-S-Bridged Cross-Link between Three Residues C22, C44, and K61 Is Frequently Observed in the SARS-CoV-2 Main ProteaseKai S Yang, Lauren R Blankenship, Syuan-Ting Alex Kuo, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|June 29, 2026
Ubiquitin Chloromethylketone Probe Enables Activity-based, Selective Protein Profiling of E2 Ubiquitin Conjugating EnzymesSaibal Chanda, Alan Pham, Yugendar R Alugubelli, et al.
Chemmedchem|August 23, 2021
Drug Repurposing for the SARS-CoV-2 Papain-Like ProteaseChia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, et al.
Biochemistry|April 15, 2026
Phage Display Driven Identification and Computational Mapping of Macrocyclic Peptides Targeting RhoA G17VSebin Abraham, Chaoyang Zhu, Lai Hoang Son Le, et al.
Chemmedchem|July 9, 2021
MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin LXinyu R Ma, Yugendar R Alugubelli, Yuying Ma, et al.
Journal of the American Chemical Society|March 28, 2020
Expressed Protein Ligation without InteinYuchen Qiao, Ge Yu, Kaci C Kratch, et al.
ACS Chemical Biology|September 29, 2022
Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2J Trae Hampton, Tyler J Lalonde, Jeffery M Tharp, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Bepridil is potent against SARS-CoV-2 In VitroErol C Vatansever, Kai Yang, Kaci C Kratch, et al.
Current Research in Chemical Biology|July 11, 2022
Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main proteaseKai S Yang, Syuan-Ting Alex Kuo, Lauren R Blankenship, et al.
ACS Central Science|April 29, 2024
Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein InhibitorsPeng-Hsun Chase Chen, Xuejiao Shirley Guo, Hanyuan Eric Zhang, et al.
ACS Chemical Biology|January 11, 2023
A Novel Y-Shaped, S-O-N-O-S-Bridged Cross-Link between Three Residues C22, C44, and K61 Is Frequently Observed in the SARS-CoV-2 Main ProteaseKai S Yang, Lauren R Blankenship, Syuan-Ting Alex Kuo, et al.
Pageof 7